OFI Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

OFI Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$100K	Sell	5,859 -166	-3%	-$3.03K	0.01%	1473
2015 Q2	$112K	Buy	6,025 +602	+11%	+$11.2K	0.01%	1464
2015 Q1	$103K	Sell	5,423 -197	-4%	-$3.64K	0.01%	1497
2014 Q4	$93K	Buy	5,620 +884	+19%	+$15.2K	0.01%	1504
2014 Q3	$84K	Buy	4,736 +397	+9%	+$7.8K	0.01%	1507
2014 Q2	$90K	Buy	4,339 +632	+17%	+$13K	0.01%	1493
2014 Q1	$81K	Buy	3,707 +737	+25%	+$16.9K	0.01%	1491
2013 Q4	$79K	Buy	2,970 +509	+21%	+$12.5K	0.01%	1493
2013 Q3	$58K	Buy	2,461 +290	+13%	+$6.77K	0.01%	1513
2013 Q2	$47K	Buy	+2,171	New	+$46.8K	﹤0.01%	1524

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

OFI Advisors's VIVO Position: Q3 2015 in Review

OFI Advisors reduced its Meridian Bioscience Inc (VIVO) stake by 2.8% in Q3 2015, selling an estimated $3.03K and leaving 5,859 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #1473.

OFI Advisors first reported a position in VIVO in Q2 2013 and has held it in 10 quarters since. The position peaked at $112K in Q2 2015. 175 funds tracked by Wall St. Rank hold VIVO as of Q3 2015.

OFI Advisors held 5,859 shares of Meridian Bioscience Inc worth $100K as of Q3 2015.
OFI Advisors sold 166 Meridian Bioscience Inc shares in Q3 2015, an estimated $3.03K.
Meridian Bioscience Inc made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1473 holding.
OFI Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Meridian Bioscience Inc position peaked at $112K in Q2 2015.
175 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.